Etzer Darout analyst BMO

Currently out of the existing stock ratings of Etzer Darout, 47 are a BUY (72.31%), 18 are a HOLD (27.69%).

Etzer Darout

Work Performance Price Targets & Ratings Chart

Analyst Etzer Darout works at BMO with a stock forecast success ratio of 45.93% fulfilled within 113.14 days on average. Previously, Etzer Darout worked at GUGGENHEIM.

Etzer Darout’s has documented 131 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 12-Feb-2024.

Wall Street Analyst Etzer Darout

Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for FATE (FATE THERAPEUTICS) at 11/9/2023. The price target of $6 was fulfilled within 83 days with a profit of $3.87 (181.69%) receiving and performance score of 21.89.

Average potential price target upside

DMAC DiaMedica Therapeutics MGNX MacroGenics MIRM Mirum Pharmaceuticals VERV Verve Therapeutics CTMX CytomX Therapeutics EXEL Exelixis FATE Fate Therapeutics GMAB Genmab AS IMGN ImmunoGen MRUS Merus BV SGEN Seagen NUVL Nuvalent XNCR Xencor FPRX Five Prime Therapeutics ALNY Alnylam Pharmaceuticals YMAB Y mAbs Therapeutics ARVN Arvinas FTSV Forty Seven AZN AstraZeneca PLC ADR CCCC C4 Therapeutics  IVA Inventiva Sa

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$5.17 (182.69%)

7 months 29 days ago

2/5 (40%)

$3.6 (81.82%)




$4.17 (147.35%)

8 months 2 days ago

0/2 (0%)

$2.95 (72.84%)


1 years 7 months 17 days ago

1/2 (50%)

$17.96 (178.88%)




$8.42 (326.36%)


2 years 7 months 25 days ago

0/2 (0%)

$6.82 (124.75%)



2 years 7 months 26 days ago

0/1 (0%)

$27.58 (264.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Etzer Darout is most bullish on?

Potential upside of $14.17 has been obtained for AZN (ASTRAZENECA PLC ADR)

Which stock is Etzer Darout is most reserved on?

Potential downside of -$8.26 has been obtained for NUVL (NUVALENT)

What Year was the first public recommendation made by Etzer Darout?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?